AI Market Mood: Stock Dashboard
TFX
Fundamental
Company: Teleflex Incorporated
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: USA
Exchange: NYSE
Index: -
P/E: -
EPS (ttm): -7.36
Insider Own: 0.75%
Shs Outstand: 44.19M
Perf Week: -2.02%
Market Cap: 5.39B
Forward P/E: 8.04
EPS next Y: 15.17
Insider Trans: 1.69%
Shs Float: 43.86M
Perf Month: 6.35%
Enterprise Value: 7.79B
PEG: 1.41
EPS next Q: 3.84
Inst Own: 106.31%
Short Float: 3.93%
Perf Quarter: 1.66%
Income: -327.97M
P/S: 1.69
EPS this Y: 0.63%
Inst Trans: -0.59%
Short Ratio: 2.66
Perf Half Y: 2.10%
Sales: 3.19B
P/B: 1.41
EPS next Y Percentage: 7.59%
ROA: -4.27%
Short Interest: 1.72M
Perf YTD: -31.46%
Book/sh: 86.48
P/C: 14.62
EPS next 5Y: 5.71%
ROE: -7.90%
52W High: 185.94 -34.40%
Perf Year: -31.57%
Cash/sh: 8.34
P/FCF: 20.39
EPS past 3/5Y: -47.52% -31.49%
ROIC: -5.05%
52W Low: 102.58 18.91%
Perf 3Y: -49.74%
Dividend Est.: 1.35 (1.11%)
EV/EBITDA: 9.16
Sales past 3/5Y: 2.74% 3.26%
Gross Margin: 53.86%
Volatility W: 2.75%
Volatility M: 3.11%
Perf 5Y: -70.17%
Dividend TTM: 1.36 (1.11%)
EV/Sales: 2.44
EPS Y/Y TTM: -245.18%
Oper. Margin: 17.79%
ATR (14): 3.99
Perf 10Y: -7.49%
Dividend Ex-Date: Nov 14, 2025
Quick Ratio: 1.53
Sales Y/Y TTM: 5.43%
Profit Margin: -10.28%
RSI (14): 51.08
Recom: 3.00
Dividend Gr. 3/5Y: 0.00% 0.00%
Current Ratio: 2.57
EPS Q/Q: -491.46%
SMA20: -0.56%
Beta: 0.94
Target Price: 132.38
Payout: 91.92%
Debt/Eq: 0.72
Sales Q/Q: 19.45%
SMA50: 1.35%
Rel Volume: 0.22
Prev Close: 122.33
Employees: 14100
LT Debt/Eq: 0.70
Earnings: Nov 06 BMO
SMA200: -1.54%
Avg Volume: 648.34K
Price: 121.98
IPO: Apr 24, 1967
Option/Short: Yes / Yes
EPS/Sales Surpr.: 7.63% 0.01%
Trades:
Volume: 123,996
Change: -0.29%
Technical:
Latest News:
Wells Fargo Sticks to Its Hold Rating for Teleflex (TFX) | Markets Insider neutral
TFX TFX
Summary: Analysts from Wells Fargo, Needham, and JMP Securities recently provided ratings on Teleflex (TFX) with varying perspectives. Teleflex reported a quarterly revenue of $773.91 million, slightly higher than the previous year, but with a lower net profit. The company provides medical technology products focused on improving patient outcomes and safety.
Full article2024-05-03T18:12:46Z